Penumbra (PEN) Long-Term Deferred Tax (2014 - 2026)
Penumbra's (PEN) quarterly Long-Term Deferred Tax came in at $80.0 million in Q1 2026, down 21.87% year-on-year from $102.4 million in Q1 2025, and up 0.99% on a QoQ basis from $79.2 million in Q4 2025.
Penumbra (PEN) Long-Term Deferred Tax (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Long-Term Deferred Tax data on file, last reported at $80.0 million in Q1 2026.
- On a quarterly basis, Long-Term Deferred Tax fell 21.87% year-over-year to $80.0 million in Q1 2026; TTM through Mar 2026 was $80.0 million, a 21.87% decrease from a year earlier, with the FY2025 full-year figure at $79.2 million, down 21.07% from the prior year.
- Long-Term Deferred Tax for Q1 2026 stood at $80.0 million, up from $79.2 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for PEN reached as high as $109.1 million in Q2 2025 and fell as low as $62.8 million in Q3 2022.
- Historically, Long-Term Deferred Tax has averaged $83.0 million across 5 years, with a median of $80.0 million in 2026.
- Across the five-year window, Long-Term Deferred Tax soared 64.78% in 2024 and slipped 21.87% in 2026, its largest moves.
- Year by year, Long-Term Deferred Tax stood at $64.2 million in 2022, then surged by 32.62% to $85.2 million in 2023, then climbed by 17.82% to $100.3 million in 2024, then fell by 21.07% to $79.2 million in 2025, then grew by 0.99% to $80.0 million in 2026.
- Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $80.0 million in Q1 2026, $79.2 million in Q4 2025, and $94.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.97 Mn |
| Dec 31, 2025 | 79.19 Mn |
| Sep 30, 2025 | 94.48 Mn |
| Jun 30, 2025 | 109.14 Mn |
| Mar 31, 2025 | 102.36 Mn |
| Dec 31, 2024 | 100.33 Mn |
| Sep 30, 2024 | 105.85 Mn |
| Jun 30, 2024 | 108.85 Mn |
| Mar 31, 2024 | 84.66 Mn |
| Dec 31, 2023 | 85.16 Mn |
| Sep 30, 2023 | 64.24 Mn |
| Jun 30, 2023 | 66.67 Mn |
| Mar 31, 2023 | 65.17 Mn |
| Dec 31, 2022 | 64.21 Mn |
| Sep 30, 2022 | 62.83 Mn |
| Jun 30, 2022 | 68.40 Mn |
| Mar 31, 2022 | 70.08 Mn |
| Dec 31, 2021 | 65.70 Mn |
| Sep 30, 2021 | 49.45 Mn |
| Mar 31, 2021 | 48.98 Mn |